Investing in well-designed cardiometabolic health checks linked to care pathways would significantly reduce burden of cardiovascular disease in Europe.

Cardiovascular disease (CVD) is often discussed through statistics, targets, and system costs. Those figures are important, but they can sometimes obscure a simple reality: across Europe, almost everyone will know someone affected by heart disease, stroke, diabetes, obesity, or high blood pressure. Earlier detection and better prevention can make a meaningful difference, not only for individuals at risk but also for families, communities, and health systems.